Brief: Kazia Therapeutics Posts Loss For Year Attributable A$20.5 Mln
Aug 31 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* LOSS FOR YEAR ATTRIBUTABLE A$20.5 MILLION VERSUS LOSS
A$25.0
MILLION
* ENTITY IS NOT GENERATING REVENUES AND IS NOT EXPECTED TO
DO SO
IN FORESEEABLE FUTURE
Source text for Eikon: ID:nASXcbQbP1
Further company coverage: KZA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kazia Therapeutics
See all newsBrief: Kazia Therapeutics Files For Mixed Shelf Of Up To $100 Million – SEC Filing
Brief: Kazia Announces Voluntary Delisting From ASX
Australia's Kazia Therapeutics slumps to 1-yr low on delisting announcement
Brief: Kazia Therapeutics Announces Intention To Voluntarily De-List From ASX
Brief: Kazia Therapeutics Seeks Trading Halt